chartexchange

BIB
ProShares Ultra NASDAQ Biotechnology
stockNASDAQETF

At CloseNov 18, 2026
54.19USD-50.669%(-55.66)3,766
Loading…
Loading…
HQ
MD, USA
Previous Close
$109.85
Beta
1.82
52-Week High
$126.40 2026-08-19
52-Week Low
$54.19 2026-11-18
SMA 50
$112.09
SMA 200
$96.73
Avg. Vol 10D
8,240
Avg. Vol 30D
8,244
Avg. Vol 90D
9,157
Relative Vol
0.46
880,000
880,000
2.5400%
Sep 21, 2010 · $0.088
May 20, 2015 · 2-for-1
BIB Profile

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

BIB Performance
PeriodPriceDateChangeBeta
1W117.412026-11-12-7.44%-15.669
1M107.092026-10-19+1.48%2.374
3M126.222026-08-19-13.90%2.357
6M77.302026-05-19+40.58%1.671
1Y76.392025-11-19+42.25%1.822
2Y53.522024-11-19+103.05%—
5Y85.222021-11-19+27.52%1.621
BIB Stock Summary

ProShares Ultra NASDAQ Biotechnology (NASDAQ:BIB) stock price today is $108.67, and today's volume is 3,766. BIB is down 1.074% today. The 30 day average volume is 8,244. BIB market cap is $95.63M with 880,000 shares outstanding.